Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and helps prevent NSAID‑induced gastric ulcers in adult patients.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole (Nexium) is used to manage conditions associated with excess gastric acid production.

- Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Erosive esophagitis: facilitates mucosal healing and prevents progression of erosive lesions. - Peptic ulcer disease: promotes ulcer healing and reduces recurrence risk. - Prevention of NSAID‑induced gastric ulcers: decreases incidence of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

Common side effects are generally mild and may resolve without intervention.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Anaphylaxis: life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin rash. - Elevated liver enzymes: potential hepatic injury. - Hypomagnesemia: low serum magnesium levels. - Acute interstitial nephritis: kidney inflammation.

Before initiating therapy, consider patient‑specific factors and monitor appropriately.

- Renal impairment: assess renal function and monitor electrolytes. - Hepatic impairment: use with caution; monitor liver enzymes. - Elderly patients: increased risk of electrolyte disturbances; monitor closely. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Drug interactions: review concomitant medications, especially those affecting gastric pH. - Store below 25°C: keep in original container, protect from light and moisture.

Esomeprazole may alter the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - Warfarin: potential increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations. - Methotrexate: reduced renal clearance, possible toxicity. - Rilpivirine (antiretroviral): decreased exposure, may require dose adjustment.